Leukotriene D5

Metabolite details

Identifier

RWLDHKGRPLNPBN-DSJHTHEWSA-N

InChI Key

RWLDHKGRPLNPBN-DSJHTHEWSA-N

IUPAC name

(5R,6S,7E,9E,11Z,14Z,17Z)-6-[(2R)-2-amino-3-(carboxymethylamino)-3-oxopropyl]sulanyl-5-hydroxyicosa-7,9,11,14,17-pentaenoic acid

Preferred name

Leukotriene D5

INN name

—

Synonym

—

ChEBI

CHEBI:175815

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Effects of Radiofrequency Field from 5G Communications on fecal microbiome and metabolome profiles in mice
• TGF-β uncouples glycolysis and inflammation in macrophages and controls the survival during sepsis

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Control_vs_nsPEF_7_day
• G1_PBS_vs_G2_DSS
• Sham_vs_Radiofrequency
• Control_vs_TGF-beta_Treatment